![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
"An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics (Nasdaq: VTGN)." Expert Review of Neurotherapeutics, 20(4), pp. 311–312
Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Taylor & Francis.
Declaration of interest
The interviewee is the chief executive officer and director of VistaGen Therapeutics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed.
Additional information
Funding
This interview was not funded.